or Try an Advanced Search...

    Rare Diseases Stocks List

    Symbol Grade Name % Change
    AURA C Aura Biosciences, Inc. 2.74
    TARA C ArTara Therapeutics, Inc. 3.90
    KROS D Keros Therapeutics, Inc. 2.07
    ALDX D Aldeyra Therapeutics, Inc. 3.78
    PHVS D Pharvaris N.V. 0.05
    LRMR D Larimar Therapeutics, Inc. 0.66
    TAK D Takeda Pharmaceutical Company Limited -0.15
    RARE F Ultragenyx Pharmaceutical Inc. 0.26
    MREO F Mereo BioPharma Group plc 1.82
    CYTH F Cyclo Therapeutics, Inc. -1.24
    View As Page of Charts
    Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Medical Devices
    Related Stock Lists: Biotechnology Biopharmaceutical Life Sciences Cancer Drug Discovery Hematology Medicine Molecule Product Organ Systems Pharmacy Syndromes Acid Alzheimer's Disease Anemia Angioedema Arcturus Therapeutics Ataxia Autoimmune Disease Biologics Bone

    Related ETFs - A few ETFs which own one or more of the above listed Rare Diseases stocks.

    Symbol Grade Name Weight
    HELX D Franklin Genomic Advancements ETF 4.7
    SBIO C ALPS Medical Breakthroughs ETF 3.39
    BBP C BioShares Biotechnology Products Fund 2.97
    PSCH C PowerShares S&P SmallCap Health Care Portfolio 2.97
    JFWD B Jacob Funds Inc. Jacob Forward ETF 2.46
    View all Rare Diseases ETFs...
    Compare ETFs
    Compare BBP to PSCH Compare PSCH to JFWD Compare SBIO to JFWD

        Rare Diseases Stocks Recent News

        Date Stock Title
        Nov 21 TAK Takeda and Alloy Therapeutics partner to make off-the-shelf CAR-T therapies
        Nov 20 TAK Takeda in deal with Alloy Therapeutics to develop cell therapy platforms for cancer
        Nov 19 ALDX ALDX Up as FDA Accepts Resubmitted NDA for Eye Drug Reproxalap
        Nov 18 ALDX Aldeyra announces FDA acceptance of resubmitted reproxalap application
        Nov 18 LRMR Larimar Therapeutics Presents Additional Data from Phase 1 Studies and Phase 2 Dose Exploration Study Supporting the Nomlabofusp Clinical Program at ICAR 2024
        Nov 18 ALDX Aldeyra Therapeutics Announces FDA Acceptance for Review of Reproxalap New Drug Application for the Treatment of Dry Eye Disease, Expands AbbVie Option Agreement
        Nov 15 TARA Protara Therapeutics to Present New Interim Data from Phase 2 ADVANCED-2 Trial of TARA-002 in Patients with NMIBC at the 25th Annual Meeting of the Society of Urologic Oncology
        Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Medical Devices
        Related Stock Lists: Epidermolysis Bullosa Genodermatoses Disease Medicine Biotechnology Clinical Development Clinical Medicine Dermatology Gene Therapy Life Sciences Medical Genetics Organ Systems Acid Acute Pain Aesthetics Amphetamine Ataxia Attention Deficit Hyperactivity Disorder Biopharmaceutical Bone
        Rare Diseases

        Rare diseases are medical conditions that affect a small percentage of the population. They are often genetic, chronic, and progressive, and can cause significant physical and mental disability. There are over 7,000 rare diseases, and many of them have no known cure.

        Browse All Tags